arrow_back Back Filing freshness 20-F FY 2025 SEC EDGAR

Sol-Gel Technologies Ltd.

SLGL
$65.49 ▼ -0.21 (-0.32%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
12 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

Sol-Gel Technologies Ltd. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $182.4M
Dividend Yield —
Revenue Growth 68.0% ↘
Op. Margin -38.9% ↗
ROIC -26.1% ↗
FCF / Share $0.10 ↗
Trailing P/E —
Price / Book 8.0x
FCF Yield 0.2%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

12-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$19.39M
↑ +68.0% —
Net Income Profit after all expenses
$-6.13M
↑ +42.1% —
Operating Margin Operating profit as % of sales
-38.9%
↑ +62.7% 6th
FCF / Share Free cash flow per share
$0.10
↑ +102.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑
15
Returns
25
Cash Quality ↑
20

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 12 years · 12 quarters